CD274 and neoplasm: Considering that PD-L1 expression is immunologically active by suppressing the activation of tumor-associated T cells (9, 25), we checked the kinetics of PD-L1 expression on these DLBCL cell lines in response to Vγ9Vδ2 T lymphocytes.